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Physical activity on prescription in primary care 
Impact on physical activity level, metabolic health and health-related quality  
of life, and its cost-effectiveness – a short- and long-term perspective 
Stefan Lundqvist 
Unit of Physiotherapy, Department of Health and Rehabilitation, Institute of Neuroscience  
and Physiology, Sahlgrenska Academy, University of Gothenburg, Sweden, 2020. 
Abstract 
Strong evidence indicates a relationship between regular physical activity (PA) and positive health effects,  
and that PA can be used to prevent and treat diseases. In Sweden, licensed healthcare professionals offer physical 
activity on prescription (PAP) as a method of supporting patients to increase their PA level. However, further 
studies are needed to elucidate clinically feasible and effective PAP treatment strategies. The Gothenburg PAP 
study on which this thesis is based, started in 2010 at 15 health care centers (HCC) by offering PAP to 444 patients 
(aged 27-85 years) who were physically inactive with metabolic risk factors and following them for 5 years. 
The overall aim of this thesis was to evaluate the Swedish PAP treatment regarding PA level, metabolic  
health, and health-related quality of life (HRQOL), and to explore factors that may predict increased PA levels.  
In addition, this thesis evaluated two different PAP treatment strategies, supported by either the HCC or a physio- 
therapist (PT), for patients who still had not reached a sufficient physical activity level after a prior 6-month period 
of PAP treatment. The cost-effectiveness of the two strategies was evaluated in a health economics study. 
A prospective observational study evaluated 6 months of PAP treatment in daily clinical care at the HCC.  
Of 368 patients, 73% increased their PA level and 42% moved from an inadequate PA level to sufficient according 
to public health recommendations. Significant improvements were seen in a majority of the metabolic risk factors 
and HRQOL components measured (Paper I). We also identified potential predictive factors for increased PA after 
a 6-month PAP intervention: positively valued confidence in readiness to change, and physical health, and BMI 
<30 kg/m2. Among patients with the lowest PA levels at baseline, 84% had increased their PA level at the 6-month 
follow-up. (Paper II). 
In a randomized controlled trial, 190 patients who still had not achieved sufficient PA levels after 6 months of  
PAP treatment, described in Papers I and II, were randomized to continued, 2-year PAP intervention supported 
either by a PT or the HCC. Both long-term PAP interventions increased the PA level, metabolic health, and 
HRQOL with no difference between groups. Results appeared to be independent of any changes in 
pharmacological treatment (Paper III). In a health economic evaluation of 3 years of PAP treatment, a cost-
effectiveness analysis compared the two PAP treatment strategies described in Paper III. From the societal 
perspective, the cost per gained quality adjusted life years (QALY) for the PT group compared to the HCC group 
was 147 250 SEK. The willingness to pay for a QALY needed to be > 150 000 SEK for the PT strategy to be a 
cost-effective choice compared to the HCC strategy indicating a moderate level of costs per QALY. Due to similar 
results in both groups, it was not possible to draw certain conclusions about the most cost-effective strategy; none 
of strategies could certainly be chosen before the other (Paper IV).  
In summary, this thesis shows that, in ordinary primary health care, both short- and long-term PAP treatment can 
be a feasible intervention to increase PA, metabolic health, and HRQOL in patients who are physically inactive and 
have at least one metabolic risk factor. The identification of predictive factors for increased PA levels and the 
benefit of long-term PAP is essential. These findings offer clinicians an opportunity to better support patients’ 
behavioral changes and the individualization of PAP treatment, and may also create the opportunity for more 
widespread use of PAP as an important method of gaining health benefits for physically inactive patients. 
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